Female Subjects Undergoing Controlled Ovarian Hyperstimulation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Female Subjects Undergoing Controlled Ovarian Hyperstimulation trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Female Subjects Undergoing Controlled Ovarian Hyperstimulation trials you may qualify forFollicle-stimulating hormone (FSH) plays a central role in controlled ovarian stimulation (COS) during in vitro fertilization (IVF) cycles. While baseline FSH i…
This is a multicentre, open-label, dose-finding, phase 2 study that will recruit approximately 90 female subjects undergoing COH for in vitro fertilization (IVF…
This study is a multi-center, randomized, double-blind, positive drug-controlled, non-inferiority Phase III clinical trial. The study will enroll approximately…
This study is a multicentre, open-label phase II dose-finding clinical trial that will recruit approximately 120 female subjects undergoing COH for in vitro fer…
To explore the optimal effective daily dose of BG2109 to suppress premature luteinizing hormone (LH) surge during COH in female subjects undergoing ART procedur…